Seeing Is Believing
Currently out of the existing stock ratings of Jack Allen, 12 are a HOLD (30.77%), 27 are a BUY (69.23%).
Analyst Jack Allen works at BAIRD with a stock forecast success ratio of 44.22% fulfilled within 28.2 days on average.
Jack Allen’s has documented 75 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACLX, Arcellx at 29-Feb-2024.
Analyst best performing recommendations are on CRSP (CRISPR THERAPEUTICS AG).
The best stock recommendation documented was for ACLX (ARCELLX) at 4/13/2023. The price target of $39 was fulfilled within 8 days with a profit of $9.7 (33.11%) receiving and performance score of 41.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$4.6 (135.29%)
9
1 months 28 days ago
0/3 (0%)
$2.86 (55.64%)
Buy
10
$6.6 (194.12%)
12
3 months 5 days ago
1/7 (14.29%)
$6.91 (223.62%)
28
Buy
10
$6.6 (194.12%)
12
3 months 5 days ago
0/5 (0%)
$6.91 (223.62%)
Buy
18
3 months 16 days ago
2/9 (22.22%)
$12.2 (210.34%)
94
Hold
35
3 months 19 days ago
1/2 (50%)
$19.71 (128.91%)
6
Which stock is Jack Allen is most bullish on?
Which stock is Jack Allen is most reserved on?
What Year was the first public recommendation made by Jack Allen?